BIOLYPH Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BIOLYPH's estimated annual revenue is currently $5M per year.(i)
  • BIOLYPH's estimated revenue per employee is $155,000

Employee Data

  • BIOLYPH has 32 Employees.(i)
  • BIOLYPH grew their employee count by 3% last year.

BIOLYPH's People

NameTitleEmail/Phone
1
Founder, Managing Director & GovernorReveal Email/Phone
2
Project ManagerReveal Email/Phone
3
Senior Production ManagerReveal Email/Phone
4
HR ManagerReveal Email/Phone
5
ControllerReveal Email/Phone
6
Client Services FacilitatorReveal Email/Phone
7
Application ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M509%N/AN/A
#2
$7.4M48-35%N/AN/A
#3
$0.9M620%N/AN/A
#4
$0.3M2-91%N/AN/A
#5
$3.6M235%N/AN/A
#6
$0.9M6-33%N/AN/A
#7
$5M323%N/AN/A
#8
$14.7M959%N/AN/A
#9
$14.7M950%$20.5MN/A
#10
$27.9M14413%$39.1MN/A
Add Company

What Is BIOLYPH?

BIOLYPH has the production processes to convert manufacturers’ unstable reagents into stable LyoSpheres™ and the disposable devices to deliver rehydrated lyophilized reagents. LyoSpheres™ are microliter aliquots of reagents that are lyophilized as precise and durable spheres and packaged inside most delivery devices. This capability allows incompatible reagents to coexist compatibly in a shelf-stable environment while awaiting rehydration. BIOLYPH has also developed a line of Lyophilized Reagent Delivery Systems named ReActivator™. ReActivator™ incorporates manufacturers’ preportioned lyophilized reagents and diluents together inside an easy-to-use, disposable, unit-of-use rehydrating dispenser providing your customers with convenient, precise, contaminant-free reagents.

keywords:N/A

N/A

Total Funding

32

Number of Employees

$5M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.2M32-6%N/A
#2
$6.4M32-18%N/A
#3
$3.5M32-9%N/A
#4
$7.3M32-3%N/A
#5
$6.4M320%N/A